Suppr超能文献

通过重复给予大麻提取物或δ1-四氢大麻酚产生对δ1-四氢大麻酚对小鼠血浆皮质酮水平影响的耐受性。

Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.

作者信息

Pertwee R G

出版信息

Br J Pharmacol. 1974 Jul;51(3):391-7. doi: 10.1111/j.1476-5381.1974.tb10674.x.

Abstract

1 Three injections of cannabis extract (500 mg/kg s.c. given over 3 or 5 days) diminished thymus gland weight but not the weights of spleen or liver in weanling female and adult male mice kept at room temperature.2 Both cannabis extract (500 mg/kg s.c.) and Delta(1)-tetrahydrocannabinol (Delta(1)-THC; 10 and 20 mg/kg i.p.) elevated corticosterone levels in mouse plasma.3 A pretreatment that consisted of three daily subcutaneous injections of 500 mg/kg of cannabis extract and that was shown to produce tolerance to the ;cataleptic' effect of Delta(1)-THC (2 mg/kg i.v.) in mice, also produced tolerance to the effect of Delta(1)-THC (10 mg/kg i.p.) on corticosterone levels in mouse plasma. However, this pretreatment did not reduce the rise in plasma corticosterone concentration produced by immobilization.4 Tolerance to the effect of Delta(1)-THC (10 mg/kg i.p.) on corticosterone levels in mouse plasma was also produced by the pretreatment of mice with a single injection of Delta(1)-THC (10 mg/kg s.c.). Three daily injections of Delta(1)-THC (10 or 30 mg/kg s.c.) also produced tolerance.5 In a thermoneutral environment (30-32 degrees C) in which cannabis extract does not produce hypothermia, the drug no longer reduced thymus gland weight. However the effect of cannabis extract and of Delta(1)-THC on corticosterone plasma levels was the same at room temperature as at 30-32 degrees C. Tolerance to the latter effect of Delta(1)-THC was also produced equally readily under the two conditions.6 It is concluded that pretreatment with cannabis extract or Delta(1)-THC can produce tolerance to the effect of Delta(1)-THC on corticosterone levels in mouse plasma and does so without impairing the effect of immobilization stress on corticosterone release. In addition, both the rise in corticosterone plasma levels produced by cannabis or Delta(1)-THC and the development of tolerance to this effect can still take place in the absence of hypothermia.

摘要
  1. 对饲养在室温下的断奶雌性和成年雄性小鼠,皮下注射三次大麻提取物(500毫克/千克,分3天或5天注射)会使胸腺重量减轻,但脾脏和肝脏重量不受影响。

  2. 大麻提取物(500毫克/千克,皮下注射)和Δⁱ-四氢大麻酚(Δⁱ-THC;10和20毫克/千克,腹腔注射)均可提高小鼠血浆中的皮质酮水平。

  3. 一种预处理方法,即每天皮下注射三次500毫克/千克的大麻提取物,已证明该预处理可使小鼠对Δⁱ-THC(2毫克/千克,静脉注射)的“僵住”效应产生耐受性,同时也使小鼠对Δⁱ-THC(10毫克/千克,腹腔注射)对小鼠血浆皮质酮水平的影响产生耐受性。然而,这种预处理并未降低固定应激引起的血浆皮质酮浓度升高。

  4. 对小鼠单次皮下注射Δⁱ-THC(10毫克/千克)进行预处理,也可使小鼠对Δⁱ-THC(10毫克/千克,腹腔注射)对小鼠血浆皮质酮水平的影响产生耐受性。每天注射三次Δⁱ-THC(10或30毫克/千克,皮下注射)同样会产生耐受性。

  5. 在热中性环境(30 - 32摄氏度)中,大麻提取物不会产生体温过低现象,该药物也不再减轻胸腺重量。然而,大麻提取物和Δⁱ-THC对血浆皮质酮水平的影响在室温下与在30 - 32摄氏度时相同。在这两种条件下,对Δⁱ-THC的后一种效应产生耐受性的难易程度也是相同的。

  6. 得出的结论是,用大麻提取物或Δⁱ-THC进行预处理可使小鼠对Δⁱ-THC对小鼠血浆皮质酮水平的影响产生耐受性,且不会损害固定应激对皮质酮释放的影响。此外,在没有体温过低的情况下,大麻或Δⁱ-THC引起的血浆皮质酮水平升高以及对这种效应的耐受性发展仍然会发生。

相似文献

引用本文的文献

本文引用的文献

3
Effect of hormones on lympatic tissue.激素对淋巴组织的影响。
Physiol Rev. 1952 Oct;32(4):379-401. doi: 10.1152/physrev.1952.32.4.379.
5
Corticosterone elevation mediated centrally by delta 1-tetrahydrocannabinol in rats.
Eur J Pharmacol. 1971;14(1):89-92. doi: 10.1016/0014-2999(71)90128-2.
6
Fluorimetric analysis of corticoids.
Methods Biochem Anal. 1966;14:63-78. doi: 10.1002/9780470110324.ch3.
10
The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats.
Eur J Pharmacol. 1970;12(3):382-4. doi: 10.1016/0014-2999(70)90094-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验